Article
Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model.
Journal of dermatological science - 1 Mar 2015
Chen Liang, Bi Bo, Zeng Jiping, Zhou Yiqun, Yang Ping, Guo Yu, Zhu Jingjing, Yang Qingjian, Zhu Ningwen, Liu Tianyi
Abstract excerpt
BACKGROUND: Rosiglitazone (RO), a second-generation thiazolidinedione used mainly in the treatment of non-insulin-dependent diabetes mellitus, has been discovered to be a high-affinity ligand for peroxisome proliferator-activated receptor-γ (PPAR-γ). Several studies have revealed that PPAR-γ is also involved in the regulation of oxidative stress and chronic inflammation associated with aging process in vivo as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
